Tetraphase Pharmaceuticals, Inc. (TTPH) Posts Mixed Q1 Results

Tetraph Pharma (NASDAQ: TTPH) reported Q1 EPS of ($0.30), $0.03 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $2.7 million versus the consensus estimate of $2.49 million.

For earnings history and earnings-related data on Tetraph Pharma (TTPH) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Keefe, Bruyette & Woods Starts Columbia Financial Inc (CLBK) at Outperform
• OceanaGold to acquire Ausgold in a deal valued at A$776M